TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03907124 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03907124 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03907124 — Predictive Biomarker (PRD): UGT2B15 mRNA
Genes: UGT2B15; UGT2B8
Study NCT03907124 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study NCT03907124 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03907124 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study NCT03907124 — Predictive Biomarker (PRD): HTR2C mRNA
Genes: HTR2C; HTR1C
Study NCT03907124 — Predictive Biomarker (PRD): DRD1 mRNA
Genes: DRD1
Study NCT03907124 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT03907124 — Predictive Biomarker (PRD): ANKK1 mRNA
Genes: ANKK1; PKK2; SGK288
Study NCT03907124 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT03907124 — Predictive Biomarker (PRD): GRIK4 mRNA
Genes: GRIK4; GRIK
Study NCT03907124 — Predictive Biomarker (PRD): SCN2A mRNA
Genes: SCN2A; NAC2; SCN2A1; SCN2A2
Study NCT03907124 — Safety Biomarker (SAF): OPRM1
Genes: MOR1; MOP
Study NCT03907124 — Safety Biomarker (SAF): MTHFR
Study NCT00259714 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00790426 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT04445454 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01981473 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT03964142 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02527252 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02436590 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study NCT01119599 — Predictive Biomarker (PRD): HES1 mRNA
Genes: HES1; BHLHB39; HL; HRY
Study NCT04204694 — Predictive Biomarker (PRD): IFNAR1 mRNA
Genes: IFNAR1; IFNAR
Study NCT00965224 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02056080 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01219179 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04587375 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04587375 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04587375 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00370682 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04173520 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT02579460 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02579460 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03113773 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03113773 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05212558 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05398237 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT05398237 — Predictive Biomarker (PRD): PBK mRNA
Genes: PBK; TOPK
Study NCT00535262 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03058211 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Heart fatty acid-binding protein
Genes: FABP3; FABP11; MDGI
Study NCT02938026 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00903006 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00903006 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02840708 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00430716 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03779750 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT03928080 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT00790946 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00790946 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT00069446 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01250873 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01250873 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01250873 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02946281 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01298817 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01298817 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01298817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02015676 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02721667 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04247087 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT02960750 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01071681 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01071681 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03826940 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01383460 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02454387 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04123951 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01293279 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT01293279 — Predictive Biomarker (PRD): ITPA mRNA
Genes: ITPA; C20orf37; My049; OK/SW-cl.9
Study NCT03539627 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00752557 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT00752557 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01859234 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03710668 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT03710668 — Predictive Biomarker (PRD): TREM2 mRNA
Genes: TREM2
Study NCT03710668 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02187627 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01222026 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01715480 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT03802747 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00688558 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT01601535 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT04123743 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study NCT04123743 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study NCT03386279 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03386279 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02485691 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00225901 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT02997501 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01768637 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01288820 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00874146 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04085354 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06427720 — Monitoring Biomarker (MOI): miR-301a-3p
Genes: MIR301A
Study NCT01588431 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02679924 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01491802 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT04466657 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01409382 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01409382 — Safety Biomarker (SAF): BDNF
Study NCT00729872 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01559649 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03056989 — Predictive Biomarker (PRD): SPX mRNA
Genes: SPX; C12orf39
Study NCT04203459 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT04203459 — Predictive Biomarker (PRD): ACAT1 mRNA
Genes: ACAT1; ACAT; MAT
Study NCT01609543 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01609543 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02882529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02769403 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04355247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04355247 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04355247 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01298869 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01298869 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02585089 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02585089 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02585089 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study NCT02123186 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT04236986 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT03417895 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04535804 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT04535804 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04535804 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04535804 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04535804 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03195166 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01310465 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02177591 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02659800 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01324596 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT03152526 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03152526 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05367115 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT01522469 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06063044 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT03840863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03107273 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04241601 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00747682 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT00747682 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05229484 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00930891 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00930891 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02219646 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02219646 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00001629 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03694275 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT00743301 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00743301 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT01499498 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study NCT03362047 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01138423 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01138423 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01993043 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01149109 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02143297 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02749032 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04530461 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04310592 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04310592 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03656536 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT01127893 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00052052 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00423137 — Predictive Biomarker (PRD): MUC2 mRNA
Genes: MUC2; SMUC
Study NCT00423137 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study NCT00423137 — Predictive Biomarker (PRD): MUC5B mRNA
Genes: MUC5B; MUC5
Study NCT00423137 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04556149 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02355184 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00197704 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00712998 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00431080 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02079376 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05464797 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT00140985 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03973359 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04137159 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study NCT00768079 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT04525768 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT02475265 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03148860 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03148860 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT02729662 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT02729662 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT03128177 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04702542 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01865266 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00535782 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02023411 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03643601 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00585832 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00512226 — Predictive Biomarker (PRD): Liver iron
Study NCT00080132 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03599882 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT01795846 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01527695 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT03256591 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT00812981 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00734851 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03447431 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01965600 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT01965600 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05371340 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03861325 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT01288521 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT01288521 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03117231 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT03520153 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study NCT04515979 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04515979 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04515979 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03191682 — Predictive Biomarker (PRD): PTP4A3 mRNA
Genes: PTP4A3; PRL3
Study NCT01638663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00072007 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study NCT00140816 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02844829 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02844829 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT01700894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04825301 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04387812 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT00729157 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00100087 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00006393 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study NCT02317315 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02000193 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02000193 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04100759 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00952991 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04585724 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02930031 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03788057 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02314663 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02314663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03202940 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00210197 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02341131 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03309462 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03309462 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03014674 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT02335931 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03271554 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02621112 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT04228588 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT01872065 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT02842827 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT06239155 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT00653666 — Predictive Biomarker (PRD): CPT1A mRNA
Genes: CPT1A; CPT1
Study NCT03214016 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03104439 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04435366 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04435366 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04109820 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00350116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01156220 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04205630 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04205630 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01941745 — Predictive Biomarker (PRD): SCGB1A1 mRNA
Genes: SCGB1A1; CC10; CCSP; UGB
Study NCT05109884 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05109884 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01428388 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01428388 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00752063 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00752063 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00752063 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00752063 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01134120 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03564288 — Predictive Biomarker (PRD): SKI mRNA
Genes: SKI
Study NCT00921271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02475239 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03091725 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196